SCHEMBL7322188

SCHEMBL7322188

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(OCCCN3CCN(C)CC3)cc2)C(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.66
ITGB3 P05106 2/20 0.55
ITGA2B P08514 2/20 0.55
ITGB1 P05556 7/20 0.55
ITGA5 P08648 3/20 0.55
ITGAV P06756 2/20 0.50
ITGB7 P26010 1/20 0.50
ALDH1A1 P00352 1/20 0.49
FKBP1A P62942 2/20 0.47
KMT2A Q03164 1/20 0.46
ITGA2 P17301 1/20 0.46
MMP1 P03956 1/20 0.45
ADAM17 P78536 1/20 0.45
TSHR P16473 1/20 0.45
KCNQ1 P51787 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7318157 0.94 ITGA4 (0.65) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7510457 0.93 ITGA4 (0.63) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7318497 0.93 ITGA4 (0.59) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7314294 0.91 ITGA4 (0.66) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7315890 0.91 ITGA4 (0.65) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7317528 0.91 ITGA4 (0.65) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7508252 0.90 ITGA4 (0.56) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL9068818 0.89 ITGA4 (0.56) ITGA4ITGB3ITGA2BITGB1ITGA5
SCHEMBL7321689 0.88 ITGA4 (0.65) ITGA4ITGB1ITGA5ITGAVITGB7
SCHEMBL7314322 0.88 ITGA4 (0.65) ITGA4ITGB3ITGA2BITGB1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed